比利時Innogenetics www.innogenetics.com www.solvay.com
Innogenetics為比利時分子診斷公司 INNOGENETICS 專心致力于研究 Infectious Diseases, Genetic Testing, Transplantation, Neurodegeneration and Oncology 等領(lǐng)域范圍的 diagnostic marker, 主力產(chǎn)品為 : HIV I/II score, HTLV I/II score, HBV DR v2, HBV genotyping, HBV PreCore, HPV Genotyping, HIV Antigen mAb, Mycobacteria 等等肝炎之偵測 . 
2010年Fujirebio 完成收購比利時Innogenetics

INNOGENETICS NV is an international biotechnology company that develops and markets diagnostic assays in the fields of Infectious Diseases, Genetic Testing, Transplantation, Neurodegeneration, and Oncology, with a special focus on molecular diagnostics and multiparameter testing.

Innogenetics is a Solvay Pharmaceuticals company. Solvay Pharmaceuticals is the global pharmaceuticals sector of the Solvay Group.